Bortezomib or Carfilzomib with Lenalidomide and Dexamethasone in Treating Patients with Newly Diagnosed Multiple Myeloma

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Basic Trial Information

PhaseTypeStatusAgeTrial IDs
Phase IIIBiomarker/Laboratory analysis, Supportive care, TreatmentActive18 and overE1A11
NCI-2012-02608, ECOG-E1A11, NCT01863550

Trial Description

Summary

This randomized phase III trial studies bortezomib, lenalidomide, and dexamethasone to see how well they work compared to carfilzomib, lenalidomide, and dexamethasone in treating patients with newly diagnosed multiple myeloma. Bortezomib and carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Lenalidomide may help the immune system kill abnormal blood cells or cancer cells. Drugs used in chemotherapy, such as dexamethasone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether bortezomib, lenalidomide, and dexamethasone are more or less effective than carfilzomib, lenalidomide, and dexamethasone in treating patients with multiple myeloma

Further Study Information

PRIMARY OBJECTIVES:

I. To compare the overall survival between two strategies of lenalidomide maintenance following induction with a proteasome inhibitor– immunomodulatory drug (IMiD) combination: limited duration of maintenance (24 months) versus indefinite maintenance therapy until disease progression.

SECONDARY OBJECTIVES:

I. To compare the progression-free survival between two strategies of lenalidomide maintenance following induction with a proteasome inhibitor–IMiD combination: limited duration of maintenance (24 months) or indefinite maintenance therapy until disease progression.

II. To compare progression-free survival between bortezomib, lenalidomide, and dexamethasone (VRd) and carfilzomib, lenalidomide, and dexamethasone (CRd) induction followed by lenalidomide maintenance in patients with newly diagnosed symptomatic multiple myeloma.

III. To compare induction rates of response between VRd and CRd arms.

IV. To evaluate time to progression, duration of response and overall survival between VRd and CRd induction therapy.

V. To compare induction rates of toxicity between VRd and CRd arms.

VI. To evaluate toxicity during lenalidomide maintenance.

TERTIARY OBJECTIVES:

I. To compare the short and long-term health-related quality of life impact between two strategies of lenalidomide maintenance following induction with a proteasome inhibitor–IMiD combination: limited duration of maintenance (24 months) versus indefinite maintenance therapy until disease progression.

II. To compare the impact on health-related quality of life between VRd and CRd induction therapy.

III. To evaluate the association between early induction response and change in health-related quality of life.

IV. To describe changes in health-related quality of life during the induction, active maintenance and observation phases.

V. To evaluate correlation between treatment adherence during maintenance and health-related quality of life.

VI. To compare induction minimal residual disease negativity rates between VRd and CRd arms.

VII. To compare minimal residual disease negativity rates between two strategies of lenalidomide maintenance following induction with a proteasome inhibitor–IMiD combination: limited duration of maintenance (24 months) versus indefinite maintenance therapy until disease progression.

VIII. To describe changes in minimal residual disease during the induction, active maintenance and observation phases and explore association with response.

IX. To describe the mutational profile of newly diagnosed multiple myeloma.

X. To identify mutations associated with resistance to VRd and CRd regimens.

XI. To identify expression profiles associated with minimal residual disease (MRD) negativity with each of the regimens.

XII. To determine the ability of MRD status at induction end to predict short-term and long-term overall and progression-free survival.

XIII. To estimate and compare incidence of clinically significant cardiotoxicity during and up to 6 months post induction between VRd and CRd.

XIV. To estimate and compare the incidence of subclinical myocardial dysfunction during and up to 6 months post induction between VRd and CRd.

XV. To compare changes in left ventricular ejection fraction (LVEF) and clinical cardiac events between VRd and CRd induction arms.

XVI. To describe changes in systolic blood pressure (SBP) and right ventricular systolic pressure (RVSP) (echo derived) and to compare incidence of clinically meaningful SBP and RVSP changes between VRd and CRd induction arms.

XVII. To develop a predictive model for the incidence of clinically significant cardiotoxicity over induction and up to 6 months post induction.

OUTLINE:

INDUCTION: Patients are randomized to 1 of 2 treatment arms.

ARM A: Patients receive bortezomib subcutaneously (SC) or intravenously (IV) on days 1, 4, 8, and 11 of courses 1-8 and days 1 and 8 of courses 9-12; lenalidomide orally (PO) daily on days 1-14; and dexamethasone PO daily on days 1, 2, 4, 5, 8, 9, 11, and 12 of courses 1-8 and days 1, 2, 8, and 9 of courses 9-12. Treatment repeats every 3 weeks for 12 courses in the absence of disease progression or unacceptable toxicity.

ARM B: Patients receive carfilzomib IV over 30 minutes on days 1, 2, 8, 9, 15, and 16; lenalidomide PO daily on days 1-21; and dexamethasone PO on days 1, 8, 15, and 22. Treatment repeats every 4 weeks for 9 courses in the absence of disease progression or unacceptable toxicity.

MAINTENANCE: After completion of induction therapy, patients are then randomized to 1 of 2 maintenance treatment arms.

ARM C: Patients receive lenalidomide PO daily on days 1-21. Treatment repeats every 4 weeks for 24 courses in the absences of disease progression or unacceptable toxicity.

ARM D: Patients receive lenalidomide PO daily on days 1-21. Courses repeat every 4 weeks in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed up every 3 months for 2 years, every 6 months for 3 years, and then annually for 10 years.

Eligibility Criteria

Inclusion Criteria:

STEP I: Patients must be diagnosed with symptomatic standard-risk multiple myeloma (SR-MM) within 90 days prior to registration as defined by all of the following (except gene expression profile [GEP]70 status if unknown):

No evidence of t(14;16) by fluorescence in situ hybridization (FISH) testing on bone marrow or not available

No evidence of t(14:20) by FISH testing on bone marrow or not available

No evidence of deletion 17p by FISH testing on bone marrow

  • NOTE: If the FISH result states that no immunoglobulin heavy chain (IgH) abnormality is present, both t(14;16) and t(14;20) can be considered negative; in addition, if the patient has a t(11;14) or t(4;14) translocation present, they can be considered negative for t(14;16) and t(14;20); if testing for t(14;16) or t(14;20) could not be performed for lack of sufficient material or non-availability of the probe in the test panel, patients can be enrolled on the study

Standard Risk GEP70 signature within the past 90 days (only if GEP has been done and results are available)

  • NOTE: GEP testing is NOT a requirement for the study; if the test has been done, patients found to have a GEP70 status of high-risk will not be eligible

Serum lactate dehydrogenase (LDH) =< 2 x upper limit of normal (ULN) within the past 28 days

No more than 20% circulating plasma cells on peripheral blood smear differential or 2,000 plasma cells/microliter on white blood cell (WBC) differential of peripheral blood within the past 90 days

  • NOTE: This is NOT the plasma cell % from the marrow aspirate
  • NOTE: If peripheral blood flow cytometry was done and no plasma cells reported, the following can be marked “0”

STEP I: Patients must have measurable or evaluable disease as defined by having one or more of the following, obtained within 28 days prior to randomization:

>= 1 g/dL monoclonal protein (M-protein) on serum protein electrophoresis

>= 200 mg/24 hrs of monoclonal protein on a 24 hour urine protein electrophoresis

Involved free light chain >= 10 mg/dL or >= 100 g/L AND abnormal serum immunoglobulin kappa to lambda free light chain ratio (< 0.26 or > 1.65)

Monoclonal bone marrow plasmacytosis >= 30% (evaluable disease)

Serum protein electrophoresis (SPEP), urine protein electrophoresis (UPEP), and serum free light chain (FLC) assay and bone marrow biopsy and or aspirate are required to be performed within 28 days prior to randomization

  • NOTE: UPEP (on a 24-hour collection) is required, no substitute method is acceptable; urine must be followed monthly if the baseline urine M-spike is >= 200 mg/24 hr; please note that if both serum and urine M-components are present, both must be followed in order to evaluate response
  • NOTE: The serum free light chain test is required to be done if the patient does not have measurable disease in the serum or urine; measurable disease in the serum is defined as having a serum M-spike >= 1 g/dL; measurable disease in the urine is defined as having a urine M-spike >= 200 mg/24 hr

STEP I: Hemoglobin >= 8 g/dL

STEP I: Untransfused platelet count >= 75,000 cells/mm^3

STEP I: Absolute neutrophil count >= 1000 cells/mm^3

STEP I: Calculated creatinine clearance >= 30 mL/min

STEP I: Bilirubin =< 1.5 mg/dL

STEP I: Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) and serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) < 2.5 times the upper limit of normal

STEP I: Patients must have received no more than one cycle (4 weeks or less) of prior chemotherapy and no more than 160 mg of prior dexamethasone (or equivalent dose of prednisone) for treatment of symptomatic myeloma; they should not have been exposed to lenalidomide, bortezomib or carfilzomib for treatment of symptomatic myeloma; prior radiation therapy to symptomatic lesions is allowed provided there are no residual toxicity related to radiation and blood counts that meet the study requirements

STEP I: Prior systemic glucocorticoid use for the treatment of non-malignant disorders is permitted; prior or concurrent topical or localized glucocorticoid therapy to treat non-malignant comorbid disorders is permitted

STEP I: Patients must not have active, uncontrolled seizure disorder; patients must have had no seizures in the last 6 months

STEP I: Patients must not have uncontrolled intercurrent illness including uncontrolled hypertension, symptomatic congestive heart failure, unstable angina, uncontrolled cardiac arrhythmia, uncontrolled psychiatric illness or social situation that would limit compliance with the study, or a prior history of Stevens Johnson syndrome

STEP I: Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 (performance status [PS] 3 allowed if secondary to pain)

STEP I: Patients with monoclonal gammopathy of undetermined significance or asymptomatic multiple myeloma are not eligible

STEP I: Patients must not have grade 2 or higher peripheral neuropathy by Common Terminology Criteria for Adverse Events (CTCAE) 4.0

STEP I: Patients must not have active, uncontrolled infection

STEP I: Patients may have a history of current or previous deep vein thrombosis or pulmonary embolism but must be willing to take some form of anti-coagulation as prophylaxis if they are not currently on full-dose anticoagulation

STEP I: Patients should not have New York Heart Association classification III or IV heart failure or myocardial infarction within the previous 6 months

STEP I: Patients with a history of prior malignancy are eligible provided they were treated with curative intent and do not require active therapy (currently treated basal cell, squamous cell carcinoma of the skin, or carcinoma “in situ” of the cervix or breast are not excluded)

STEP I: Females of childbearing potential (FCBP)* must have a negative serum or urine pregnancy test with a sensitivity of at least 50 mIU/mL within 10-14 days prior to and again within 24 hours of starting lenalidomide and must either commit to continued abstinence from heterosexual intercourse or begin TWO acceptable methods of birth control, one highly effective method and one additional effective method AT THE SAME TIME, at least 28 days before she starts taking lenalidomide; FCBP must also agree to ongoing pregnancy testing; all patients must be counseled at a minimum of every 28 days about pregnancy precautions and risks of fetal exposure; female subjects must agree to use contraception or abstinence for 30 days after last dose of carfilzomib

A female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has not undergone a hysterectomy or bilateral oophorectomy; or 2) has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months

STEP I: Sexually active males must be willing to use a condom (even if they have undergone a prior vasectomy) while having intercourse, while taking lenalidomide and for 4 weeks after stopping treatment; male subjects must be willing to use condoms for 90 days after discontinuation of carfilzomib

STEP I: The following patients will be excluded:

Pregnant women

Nursing women

STEP I: Human immunodeficiency virus (HIV) infection is not excluded; known HIV positive patients must meet the following criteria:

Cluster of differentiation (CD)4 cell count >= 350/mm^3

No history of acquired immune deficiency syndrome (AIDS)-related illness

Not currently prescribed zidovudine or stavudine

STEP I: Patient enrolling to this study must agree to register to the mandatory RevAssist® program, and be willing and able to comply with the requirements of RevAssist®

STEP II: Patients must not have experienced progression on step 1 induction therapy

STEP II: Step 2 registration must be within 28 days of completing step 1 therapy

STEP II: Patients must not have received any non-protocol therapy outside of the assigned induction therapy

STEP II: ECOG performance status 0, 1, or 2 (PS 3 allowed if secondary to pain)

STEP II: Any adverse event related to step 1 therapy must have resolved to grade 2 or less

STEP II: Hemoglobin >= 8 g/dL

STEP II: Platelet count >= 75,000 cells/mm^3

STEP II: Absolute neutrophil count >= 1000 cells/mm^3

STEP II: Calculated creatinine clearance >= 30 mL/min

STEP II: Bilirubin =< 1.5 mg/dL

STEP II: SGPT (ALT) and SGOT (AST) < 2.5 times the upper limit of normal

STEP II: Females of childbearing potential (FCBP)* must have a negative serum or urine pregnancy test with a sensitivity of at least 50 mIU/mL within 10-14 days prior to and again within 24 hours of starting lenalidomide and must either commit to continued abstinence from heterosexual intercourse or begin TWO acceptable methods of birth control, one highly effective method and one additional effective method AT THE SAME TIME, at least 28 days before she starts taking lenalidomide; FCBP must also agree to ongoing pregnancy testing; men must agree to use a latex condom during sexual contact with a FCBP even if they have had a successful vasectomy; all patients must be counseled at a minimum of every 28 days about pregnancy precautions and risks of fetal exposure

A female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has not undergone a hysterectomy or bilateral oophorectomy; or 2) has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months

STEP II: Sexually active males must be willing to use a condom (even if they have undergone a prior vasectomy) while having intercourse, while taking lenalidomide and for 4 weeks after stopping treatment

STEP II: The following patients will be excluded:

Pregnant women

Nursing women

STEP II: Patient enrolling to this study must agree to register to the mandatory RevAssist program and be willing and able to comply with the requirements of RevAssist

Trial Contact Information

Trial Lead Organizations / Sponsors / Collaborators

ECOG-ACRIN Cancer Research Group

  • National Cancer Institute
Shaji K. Kumar, Principal Investigator

Trial Sites

U.S.A.

Arizona
Scottsdale

Mayo Clinic in Arizona

Shaji K. Kumar
Ph: 855-776-0015

Shaji K. Kumar
Principal Investigator

Arkansas
Hot Springs

Mercy Cancer Center-Hot Springs

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Little Rock

Veteran's Administration Medical Center

Zhifu Xiang
Ph: 501-686-8274

Zhifu Xiang
Principal Investigator

California
Antioch

Kaiser Permanente-Deer Valley Medical Center

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Auburn

Sutter Auburn Faith Hospital

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Sutter Cancer Centers Radiation Oncology Services-Auburn

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Berkeley

Alta Bates Summit Medical Center-Herrick Campus

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Burlingame

Mills - Peninsula Hospitals

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Cameron Park

Sutter Cancer Centers Radiation Oncology Services-Cameron Park

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Castro Valley

Eden Hospital Medical Center

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Davis

Sutter Davis Hospital

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Fremont

Kaiser Permanente-Fremont

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Fresno

Kaiser Permanente

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Fullerton

Saint Jude Medical Center

William E. Lawler
Ph: 714-446-5642

William E. Lawler
Principal Investigator

Marysville

Fremont - Rideout Cancer Center

Aaron Rosenberg
Ph: 916-734-3089

Aaron Rosenberg
Principal Investigator

Modesto

Kaiser Permanente-Modesto

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Memorial Medical Center

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Mountain View

Palo Alto Medical Foundation-Camino Division

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Palo Alto Medical Foundation-Gynecologic Oncology

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Novato

Sutter Cancer Research Consortium

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Oakland

Kaiser Permanente-Oakland

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Orange

UC Irvine Health/Chao Family Comprehensive Cancer Center

Kanwarpal S. Kahlon
Ph: 877-827-8839
Email: ucstudy@uci.edu

Kanwarpal S. Kahlon
Principal Investigator

Palo Alto

Palo Alto Medical Foundation Health Care

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Pismo Beach

PCR Oncology

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Redwood City

Kaiser Permanente-Redwood City

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Richmond

Kaiser Permanente-Richmond

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Roseville

Kaiser Permanente-Roseville

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sutter Cancer Centers Radiation Oncology Services-Roseville

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Sutter Roseville Medical Center

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Sacramento

Kaiser Permanente - Sacramento

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Kaiser Permanente-South Sacramento

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sutter General Hospital

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

University of California Davis Comprehensive Cancer Center

Aaron Rosenberg
Ph: 916-734-3089

Aaron Rosenberg
Principal Investigator

San Francisco

California Pacific Medical Center-Pacific Campus

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Kaiser Permanente-San Francisco

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

San Jose

Kaiser Permanente-Santa Teresa-San Jose

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

San Leandro

Kaiser Permanente San Leandro

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

San Rafael

Kaiser Permanente-San Rafael

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Santa Clara

Kaiser Permanente Medical Center - Santa Clara

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Santa Cruz

Palo Alto Medical Foundation-Santa Cruz

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Santa Rosa

Kaiser Permanente-Santa Rosa

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sutter Pacific Medical Foundation

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

South San Francisco

Kaiser Permanente-South San Francisco

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Stockton

Kaiser Permanente-Stockton

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sunnyvale

Palo Alto Medical Foundation-Sunnyvale

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Truckee

Gene Upshaw Memorial Tahoe Forest Cancer Center

Aaron Rosenberg
Ph: 916-734-3089

Aaron Rosenberg
Principal Investigator

Vacaville

Kaiser Permanente Medical Center-Vacaville

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sutter Cancer Centers Radiation Oncology Services-Vacaville

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Vallejo

Kaiser Permanente-Vallejo

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Sutter Solano Medical Center/Cancer Center

Jorge Alejandro Garcia-Young
Ph: 415-209-2686
Email: bernicl@sutterhealth.org

Jorge Alejandro Garcia-Young
Principal Investigator

Walnut Creek

Kaiser Permanente-Walnut Creek

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Colorado
Aurora

Rocky Mountain Cancer Centers-Aurora

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Boulder

Boulder Community Hospital

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Boulder

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Colorado Springs

Penrose-Saint Francis Healthcare

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Rocky Mountain Cancer Centers-Penrose

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Denver

Colorado Blood Cancer Institute

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Colorado Cancer Research Program NCORP

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Denver Health Medical Center

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Kaiser Permanente-Franklin

Alexander Menter
Ph: 303-614-1300

Alexander Menter
Principal Investigator

National Jewish Health-Main Campus

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Porter Adventist Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Presbyterian - Saint Lukes Medical Center - Health One

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Midtown

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Rocky Mountain Cancer Centers-Rose

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Rose Medical Center

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

SCL Health Saint Joseph Hospital

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Durango

Mercy Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Southwest Oncology PC

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Englewood

Comprehensive Cancer Care and Research Institute of Colorado LLC

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Swedish Medical Center

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Golden

Mountain Blue Cancer Care Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

National Jewish Health-Western Hematology Oncology

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Greeley

North Colorado Medical Center

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Greenwood Village

Rocky Mountain Cancer Centers-Greenwood Village

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Lafayette

Kaiser Permanente-Rock Creek

Alexander Menter
Ph: 303-614-1300

Alexander Menter
Principal Investigator

Lakewood

Rocky Mountain Cancer Centers-Lakewood

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Saint Anthony Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Littleton

Littleton Adventist Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Rocky Mountain Cancer Centers-Littleton

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Lone Tree

Kaiser Permanente-Lone Tree

Alexander Menter
Ph: 303-614-1300

Alexander Menter
Principal Investigator

Rocky Mountain Cancer Centers-Sky Ridge

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Longmont

Longmont United Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Rocky Mountain Cancer Centers-Longmont

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Loveland

McKee Medical Center

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Parker

Parker Adventist Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Rocky Mountain Cancer Centers-Parker

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Pueblo

Rocky Mountain Cancer Centers - Pueblo

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Saint Mary Corwin Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Thornton

Rocky Mountain Cancer Centers-Thornton

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Wheat Ridge

SCL Health Lutheran Medical Center

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Connecticut
Derby

Smilow Cancer Hospital-Derby Care Center

Terri Lynn Parker
Ph: 203-785-5702

Terri Lynn Parker
Principal Investigator

Fairfield

Smilow Cancer Hospital Care Center-Fairfield

Terri Lynn Parker
Ph: 203-785-5702

Terri Lynn Parker
Principal Investigator

Guilford

Medical Oncology and Hematology Group PC-Guilford

Terri Lynn Parker
Ph: 203-785-5702

Terri Lynn Parker
Principal Investigator

Hartford

Smilow Cancer Hospital Care Center at Saint Francis

Terri Lynn Parker
Ph: 203-785-5702

Terri Lynn Parker
Principal Investigator

New Haven

Yale University

Terri Lynn Parker
Ph: 203-785-5702

Terri Lynn Parker
Principal Investigator

North Haven

Yale-New Haven Hospital North Haven Medical Center

Terri Lynn Parker
Ph: 203-785-5702

Terri Lynn Parker
Principal Investigator

Orange

Smilow Cancer Hospital-Orange Care Center

Terri Lynn Parker
Ph: 203-785-5702

Terri Lynn Parker
Principal Investigator

Torrington

Charlotte Hungerford Hospital Center for Cancer Care

Terri Lynn Parker
Ph: 203-785-5702

Terri Lynn Parker
Principal Investigator

Trumbull

Smilow Cancer Hospital Care Center-Trumbull

Terri Lynn Parker
Ph: 203-785-5702

Terri Lynn Parker
Principal Investigator

Waterbury

Smilow Cancer Hospital-Waterbury Care Center

Terri Lynn Parker
Ph: 203-785-5702

Terri Lynn Parker
Principal Investigator

Delaware
Lewes

Beebe Medical Center

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Newark

Christiana Care Health System-Christiana Hospital

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Delaware Clinical and Laboratory Physicians PA

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Helen F Graham Cancer Center

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Medical Oncology Hematology Consultants PA

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Regional Hematology and Oncology PA

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Rehoboth Beach

Beebe Health Campus

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Seaford

Nanticoke Memorial Hospital

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Wilmington

Christiana Care Health System-Wilmington Hospital

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

District of Columbia
Washington

MedStar Georgetown University Hospital

David H. Vesole
Ph: 201-996-2879

David H. Vesole
Principal Investigator

Florida
Deerfield Beach

UM Sylvester Comprehensive Cancer Center at Deerfield Beach

James E. Hoffman
Ph: 305-243-2647

James E. Hoffman
Principal Investigator

Miami

UM Sylvester Comprehensive Cancer Center at Kendall

James E. Hoffman
Ph: 305-243-2647

James E. Hoffman
Principal Investigator

University of Miami Miller School of Medicine-Sylvester Cancer Center

James E. Hoffman
Ph: 305-243-2647

James E. Hoffman
Principal Investigator

Pensacola

Sacred Heart Hospital

Tarek Eldawy (Mohamed)
Ph: 850-416-4611
Email: ttamayo@shhpens.org

Tarek Eldawy (Mohamed)
Principal Investigator

Sacred Heart Medical Oncology Group - Davis Highway

Tarek Eldawy (Mohamed)
Ph: 850-416-4611

Tarek Eldawy (Mohamed)
Principal Investigator

Plantation

UM Sylvester Comprehensive Cancer Center at Plantation

James E. Hoffman
Ph: 305-243-2647

James E. Hoffman
Principal Investigator

Georgia
Atlanta

Northside Hospital

Kathleen Elizabeth Lambert
Ph: 404-501-3279

Kathleen Elizabeth Lambert
Principal Investigator

Cumming

Northside Hospital-Forsyth

Kathleen Elizabeth Lambert
Ph: 404-501-3279

Kathleen Elizabeth Lambert
Principal Investigator

Decatur

Atlanta VA Medical Center

Chunzhi (Sarah) Xia
Ph: 404-321-6111extn7632

Chunzhi (Sarah) Xia
Principal Investigator

Savannah

Lewis Cancer and Research Pavilion at Saint Joseph's/Candler

Grant Carlton Lewis
Ph: 912-350-8568

Grant Carlton Lewis
Principal Investigator

Hawaii
Aiea

Hawaii Oncology Inc-Pali Momi

Jeffrey L. Berenberg
Ph: 808-524-6115

Jeffrey L. Berenberg
Principal Investigator

Pali Momi Medical Center

Jeffrey L. Berenberg
Ph: 808-524-6115

Jeffrey L. Berenberg
Principal Investigator

Ewa Beach

The Cancer Center of Hawaii-Leeward

Jeffrey L. Berenberg
Ph: 808-524-6115

Jeffrey L. Berenberg
Principal Investigator

Honolulu

Hawaii Cancer Care Inc-Liliha

Jeffrey L. Berenberg
Ph: 808-524-6115

Jeffrey L. Berenberg
Principal Investigator

Hawaii Cancer Care Inc-POB II

Jeffrey L. Berenberg
Ph: 808-524-6115

Jeffrey L. Berenberg
Principal Investigator

Hawaii Oncology Inc-Kuakini

Jeffrey L. Berenberg
Ph: 808-524-6115

Jeffrey L. Berenberg
Principal Investigator

Island Urology

Jeffrey L. Berenberg
Ph: 808-524-6115

Jeffrey L. Berenberg
Principal Investigator

Kaiser Permanente Moanalua Medical Center

Tatjana Kolevska
Ph: 626-564-3455

Tatjana Kolevska
Principal Investigator

Kapiolani Medical Center for Women and Children

Jeffrey L. Berenberg
Ph: 808-524-6115

Jeffrey L. Berenberg
Principal Investigator

Kuakini Medical Center

Jeffrey L. Berenberg
Ph: 808-524-6115

Jeffrey L. Berenberg
Principal Investigator

Oncare Hawaii Inc-POB I

Jeffrey L. Berenberg
Ph: 808-524-6115

Jeffrey L. Berenberg
Principal Investigator

Queen's Medical Center

Jeffrey L. Berenberg
Ph: 808-524-6115

Jeffrey L. Berenberg
Principal Investigator

Straub Clinic and Hospital

Jeffrey L. Berenberg
Ph: 808-524-6115

Jeffrey L. Berenberg
Principal Investigator

The Cancer Center of Hawaii-Liliha

Jeffrey L. Berenberg
Ph: 808-524-6115

Jeffrey L. Berenberg
Principal Investigator

University of Hawaii Cancer Center

Jeffrey L. Berenberg
Ph: 808-524-6115

Jeffrey L. Berenberg
Principal Investigator

Lihue

Wilcox Memorial Hospital and Kauai Medical Clinic

Jeffrey L. Berenberg
Ph: 808-524-6115

Jeffrey L. Berenberg
Principal Investigator

Idaho
Boise

Saint Alphonsus Cancer Care Center-Boise

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Coeur D'Alene

Kootenai Medical Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Post Falls

Kootenai Cancer Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Sandpoint

Kootenai Cancer

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Illinois
Aurora

Rush - Copley Medical Center

Vamsi Krishna Vasireddy
Ph: 800-446-5532

Vamsi Krishna Vasireddy
Principal Investigator

Bloomington

Illinois CancerCare-Bloomington

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Saint Joseph Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Canton

Illinois CancerCare-Canton

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Carbondale

Memorial Hospital of Carbondale

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Carthage

Illinois CancerCare-Carthage

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Centralia

Centralia Oncology Clinic

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Chicago

Mount Sinai Hospital Medical Center

Pam G. Khosla
Ph: 773-257-5960
Email: suhi@sinai.org

Pam G. Khosla
Principal Investigator

Presence Saint Joseph Hospital-Chicago

Ira Anton Oliff
Email: info@orchardhr.com

Ira Anton Oliff
Principal Investigator

Weiss Memorial Hospital

Jeffrey Kendrew Zawacki
Ph: 773-564-5044

Jeffrey Kendrew Zawacki
Principal Investigator

Danville

Carle on Vermilion

Vamsi Krishna Vasireddy
Ph: 800-446-5532

Vamsi Krishna Vasireddy
Principal Investigator

Decatur

Cancer Care Center of Decatur

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Decatur Memorial Hospital

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Effingham

Carle Physician Group-Effingham

Vamsi Krishna Vasireddy
Ph: 800-446-5532

Vamsi Krishna Vasireddy
Principal Investigator

Crossroads Cancer Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Eureka

Illinois CancerCare-Eureka

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Evanston

NorthShore University HealthSystem-Evanston Hospital

Jagoda Jasielec
Ph: 847-570-2109

Jagoda Jasielec
Principal Investigator

Galesburg

Illinois CancerCare-Galesburg

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Illinois CancerCare-Galesburg Cottage Plaza Office

Nguyet Anh Le-Lindqwister
Ph: 800-793-2262

Nguyet Anh Le-Lindqwister
Principal Investigator

Western Illinois Cancer Treatment Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Geneva

Northwestern Medicine Cancer Center Delnor

Robert A. Bayer
Ph: 630-315-1918
Email: Claudine.Gamster@CadenceHealth.org

Robert A. Bayer
Principal Investigator

Glenview

NorthShore University HealthSystem-Glenbrook Hospital

Jagoda Jasielec
Ph: 847-570-2109

Jagoda Jasielec
Principal Investigator

Highland Park

NorthShore University HealthSystem-Highland Park Hospital

Jagoda Jasielec
Ph: 847-570-2109

Jagoda Jasielec
Principal Investigator

Hinsdale

Hinsdale Hematology Oncology Associates Incorporated

Elyse Cheryl Schneiderman
Ph: 630-654-1790
Email: info@hhoaltd.com

Elyse Cheryl Schneiderman
Principal Investigator

Kankakee

Presence Saint Mary's Hospital

Sylvia V. Velinova Falls
Ph: 815-937-8780

Sylvia V. Velinova Falls
Principal Investigator

Kewanee

Illinois CancerCare-Kewanee Clinic

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Macomb

Illinois CancerCare-Macomb

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Mattoon

Carle Physician Group-Mattoon/Charleston

Vamsi Krishna Vasireddy
Ph: 800-446-5532

Vamsi Krishna Vasireddy
Principal Investigator

Maywood

Loyola University Medical Center

Kevin Patrick Barton
Ph: 708-226-4357

Kevin Patrick Barton
Principal Investigator

Mount Vernon

Good Samaritan Regional Health Center

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Ottawa

Illinois CancerCare-Ottawa Clinic

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Pekin

Illinois CancerCare-Pekin

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Peoria

Illinois CancerCare-Peoria

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Methodist Medical Center of Illinois

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

OSF Saint Francis Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

OSF Saint Francis Radiation Oncology at Peoria Cancer Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Peru

Illinois CancerCare-Peru

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Valley Radiation Oncology

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Princeton

Illinois CancerCare-Princeton

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

River Forest

West Suburban Medical Center

Jeffrey Kendrew Zawacki
Ph: 773-564-5044

Jeffrey Kendrew Zawacki
Principal Investigator

Rockford

SwedishAmerican Regional Cancer Center/ACT

Harvey E. Einhorn
Ph: 779-696-9400
Email: cancercare@swedishamerican.org

Harvey E. Einhorn
Principal Investigator

Skokie

North Shore Medical Center

Jagoda Jasielec
Ph: 847-570-2109

Jagoda Jasielec
Principal Investigator

Springfield

Central Illinois Hematology Oncology Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Memorial Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Southern Illinois University School of Medicine

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Springfield Clinic

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Swansea

Cancer Care Specialists of Illinois-Swansea

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Urbana

Carle Cancer Center

Vamsi Krishna Vasireddy
Ph: 800-446-5532

Vamsi Krishna Vasireddy
Principal Investigator

The Carle Foundation Hospital

Vamsi Krishna Vasireddy
Ph: 800-446-5532

Vamsi Krishna Vasireddy
Principal Investigator

Warrenville

Northwestern Medicine Cancer Center Warrenville

Robert A. Bayer
Ph: 630-315-1918
Email: Claudine.Gamster@CadenceHealth.org

Robert A. Bayer
Principal Investigator

Yorkville

Rush-Copley Healthcare Center

Vamsi Krishna Vasireddy
Ph: 800-446-5532

Vamsi Krishna Vasireddy
Principal Investigator

Indiana
Bloomington

IU Health Bloomington

Jeffrey Paul Allerton
Ph: 812-353-2831

Jeffrey Paul Allerton
Principal Investigator

Fort Wayne

Fort Wayne Medical Oncology and Hematology Inc-Parkview

Sreenivasa R. Nattam
Ph: 260-484-8830
Email: ledgar@fwmoh.com

Sreenivasa R. Nattam
Principal Investigator

Indianapolis

Indiana University/Melvin and Bren Simon Cancer Center

Rafat Abonour
Ph: 317-274-2552

Rafat Abonour
Principal Investigator

Springmill Medical Center

Rafat Abonour
Ph: 317-274-2552

Rafat Abonour
Principal Investigator

Michigan City

Franciscan Saint Anthony Health-Michigan City

Vamsi Krishna Vasireddy
Ph: 800-446-5532

Vamsi Krishna Vasireddy
Principal Investigator

Woodland Cancer Care Center

Vamsi Krishna Vasireddy
Ph: 800-446-5532

Vamsi Krishna Vasireddy
Principal Investigator

Mishawaka

Memorial Regional Cancer Center Day Road

Thomas Joseph Reid
Ph: 800-284-7370

Thomas Joseph Reid
Principal Investigator

Munster

The Community Hospital

Mohamad Kassar
Ph: 219-836-3349

Mohamad Kassar
Principal Investigator

Richmond

Reid Health

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

South Bend

Memorial Hospital of South Bend

Thomas Joseph Reid
Ph: 800-284-7370

Thomas Joseph Reid
Principal Investigator

Iowa
Ames

Mary Greeley Medical Center

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

McFarland Clinic PC-William R Bliss Cancer Center

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

Bettendorf

Hematology Oncology Associates-Quad Cities

Shobha R. Chitneni
Ph: 563-355-7733
Email: kedaprile@rccqc.com

Shobha R. Chitneni
Principal Investigator

Boone

McFarland Clinic PC-Boone

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

Cedar Rapids

Mercy Hospital

Deborah Weil Wilbur
Ph: 515-241-3305

Deborah Weil Wilbur
Principal Investigator

Oncology Associates at Mercy Medical Center

Deborah Weil Wilbur
Ph: 515-241-3305

Deborah Weil Wilbur
Principal Investigator

Clive

Medical Oncology and Hematology Associates-West Des Moines

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Mercy Cancer Center-West Lakes

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Council Bluffs

Alegent Health Mercy Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Creston

Greater Regional Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Davenport

Genesis Medical Center - East Campus

George Kovach
Ph: 800-446-6088
Email: werners@genesishealth.com

George Kovach
Principal Investigator

Des Moines

Iowa Lutheran Hospital

Robert J. Behrens
Ph: 515-282-2921

Robert J. Behrens
Principal Investigator

Iowa Methodist Medical Center

Robert J. Behrens
Ph: 515-282-2921

Robert J. Behrens
Principal Investigator

Medical Oncology and Hematology Associates-Des Moines

Robert J. Behrens
Ph: 515-282-2921

Robert J. Behrens
Principal Investigator

Medical Oncology and Hematology Associates-Laurel

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Mercy Medical Center - Des Moines

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Fort Dodge

McFarland Clinic PC-Trinity Cancer Center

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

Jefferson

McFarland Clinic PC-Jefferson

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

Marshalltown

McFarland Clinic PC-Marshalltown

Joseph James Merchant
Ph: 515-239-2621

Joseph James Merchant
Principal Investigator

Sioux City

Siouxland Regional Cancer Center

Donald B. Wender
Ph: 712-252-0088

Donald B. Wender
Principal Investigator

West Des Moines

Mercy Medical Center-West Lakes

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Methodist West Hospital

Robert J. Behrens
Ph: 515-282-2921

Robert J. Behrens
Principal Investigator

Kansas
Chanute

Cancer Center of Kansas - Chanute

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Dodge City

Cancer Center of Kansas - Dodge City

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

El Dorado

Cancer Center of Kansas - El Dorado

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Fort Scott

Cancer Center of Kansas - Fort Scott

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Independence

Cancer Center of Kansas-Independence

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Kingman

Cancer Center of Kansas-Kingman

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Lawrence

Lawrence Memorial Hospital

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Liberal

Cancer Center of Kansas-Liberal

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Newton

Cancer Center of Kansas - Newton

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Parsons

Cancer Center of Kansas - Parsons

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Pratt

Cancer Center of Kansas - Pratt

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Salina

Cancer Center of Kansas - Salina

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Wellington

Cancer Center of Kansas - Wellington

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Wichita

Associates In Womens Health

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Cancer Center of Kansas - Wichita

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Cancer Center of Kansas-Wichita Medical Arts Tower

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Wesley Medical Center

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Winfield

Cancer Center of Kansas - Winfield

Shaker R. Dakhil
Ph: 316-268-5374

Shaker R. Dakhil
Principal Investigator

Kentucky
Bardstown

Flaget Memorial Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Corbin

Commonwealth Cancer Center-Corbin

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Crestview Hills

Oncology Hematology Care Inc-Crestview

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Lexington

Saint Joseph Hospital East

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Saint Joseph Radiation Oncology Resource Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Louisville

Jewish Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Jewish Hospital Medical Center Northeast

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Saints Mary and Elizabeth Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Shepherdsville

Jewish Hospital Medical Center South

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Louisiana
Baton Rouge

Baton Rouge General Medical Center

Augusto C. Ochoa
Ph: 504-568-2428
Email: emede1@lsuhsc.edu

Augusto C. Ochoa
Principal Investigator

Louisiana Hematology Oncology Associates LLC

Augusto C. Ochoa
Ph: 504-568-2428
Email: emede1@lsuhsc.edu

Augusto C. Ochoa
Principal Investigator

LSU Health Baton Rouge-North Clinic

Augusto C. Ochoa
Ph: 504-568-2428
Email: emede1@lsuhsc.edu

Augusto C. Ochoa
Principal Investigator

Mary Bird Perkins Cancer Center

Augusto C. Ochoa
Ph: 504-568-2428
Email: emede1@lsuhsc.edu

Augusto C. Ochoa
Principal Investigator

Medical Oncology LLC

Augusto C. Ochoa
Ph: 504-568-2428
Email: emede1@lsuhsc.edu

Augusto C. Ochoa
Principal Investigator

Covington

Mary Bird Cancer Center/Saint Tammany Parish

Augusto C. Ochoa
Ph: 504-568-2428
Email: emede1@lsuhsc.edu

Augusto C. Ochoa
Principal Investigator

Houma

Mary Bird Perkins Cancer Center/Terrebonne General Medical Center

Augusto C. Ochoa
Ph: 504-568-2428
Email: emede1@lsuhsc.edu

Augusto C. Ochoa
Principal Investigator

Monroe

University Health-Conway

Srinivas Sankarnaga Devarakonda
Ph: 318-813-1412

Srinivas Sankarnaga Devarakonda
Principal Investigator

Shreveport

Louisiana State University Health Sciences Center Shreveport

Srinivas Sankarnaga Devarakonda
Ph: 318-813-1412

Srinivas Sankarnaga Devarakonda
Principal Investigator

Maine
Augusta

Harold Alfond Center for Cancer Care

Thomas H. Openshaw
Ph: 800-987-3005

Thomas H. Openshaw
Principal Investigator

Bangor

Eastern Maine Medical Center

Thomas H. Openshaw
Ph: 800-987-3005

Thomas H. Openshaw
Principal Investigator

Brewer

Lafayette Family Cancer Center-EMMC

Thomas H. Openshaw
Ph: 800-987-3005

Thomas H. Openshaw
Principal Investigator

Lewiston

Central Maine Medical Center

Daniel Cary Rausch
Ph: 207-795-8250
Email: benderli@cmhc.org

Daniel Cary Rausch
Principal Investigator

Rockport

Penobscot Bay Medical Center

Thomas H. Openshaw
Ph: 800-987-3005

Thomas H. Openshaw
Principal Investigator

York

York Hospital

Marilyn A. McLaughlin
Ph: 207-351-3777

Marilyn A. McLaughlin
Principal Investigator

Maryland
Bethesda

Walter Reed National Military Medical Center

Mary Lee Kwok
Ph: 301-319-2100

Mary Lee Kwok
Principal Investigator

Frederick

Frederick Memorial Hospital

Mark Gregory Goldstein
Ph: 240-566-3584
Email: clinicaltrials@fmh.org

Mark Gregory Goldstein
Principal Investigator

Massachusetts
Boston

Tufts Medical Center

Andreas Kirschmer Klein
Ph: 617-636-5000
Email: ContactUsCancerCenter@TuftsMedicalCenter.org

Andreas Kirschmer Klein
Principal Investigator

Lowell

Lowell General Hospital

Richard M. Zuniga
Ph: 978-788-7084
Email: ghincks@lowellgeneral.org

Richard M. Zuniga
Principal Investigator

Springfield

Baystate Medical Center

Syed S. Ali
Ph: 413-794-3565
Email: tamara.wrenn@baystatehealth.org

Syed S. Ali
Principal Investigator

Michigan
Ann Arbor

Saint Joseph Mercy Hospital

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Bay City

McLaren-Bay Region

Justin F. Klamerus
Ph: 313-576-9363

Justin F. Klamerus
Principal Investigator

Clarkston

Great Lakes Cancer Institute

Justin F. Klamerus
Ph: 313-576-9363

Justin F. Klamerus
Principal Investigator

Clinton Township

Henry Ford Macomb Hospital

Robert Anthony Chapman
Ph: 313-916-1784

Robert Anthony Chapman
Principal Investigator

Commerce

Huron Valley-Sinai Hospital

Jeffrey Allan Zonder
Ph: 313-576-9363

Jeffrey Allan Zonder
Principal Investigator

Dearborn

Beaumont Hospital-Dearborn

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Henry Ford Medical Center-Fairlane

Robert Anthony Chapman
Ph: 313-916-1784

Robert Anthony Chapman
Principal Investigator

Detroit

Henry Ford Hospital

Robert Anthony Chapman
Ph: 313-916-1784

Robert Anthony Chapman
Principal Investigator

Saint John Hospital and Medical Center

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Wayne State University/Karmanos Cancer Institute

Jeffrey Allan Zonder
Ph: 313-576-9363

Jeffrey Allan Zonder
Principal Investigator

Escanaba

Green Bay Oncology - Escanaba

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Farmington

Botsford General Hospital

Ishmael A. Jaiyesimi
Ph: 248-551-7695

Ishmael A. Jaiyesimi
Principal Investigator

Farmington Hills

Weisberg Cancer Treatment Center

Jeffrey Allan Zonder
Ph: 313-576-9363

Jeffrey Allan Zonder
Principal Investigator

Flint

Genesys Hurley Cancer Institute

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Hurley Medical Center

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Singh and Arora Hematology Oncology PC

Justin F. Klamerus
Ph: 313-576-9363

Justin F. Klamerus
Principal Investigator

Grosse Pointe

William Beaumont Hospital-Grosse Point

Ishmael A. Jaiyesimi
Ph: 248-551-7695

Ishmael A. Jaiyesimi
Principal Investigator

Iron Mountain

Green Bay Oncology - Iron Mountain

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Jackson

Allegiance Health

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Kalamazoo

West Michigan Cancer Center

Kathleen J. Yost
Ph: 616-391-1230
Email: crcwm-regulatory@crcwm.org

Kathleen J. Yost
Principal Investigator

Lansing

McLaren-Greater Lansing

Justin F. Klamerus
Ph: 313-576-9363

Justin F. Klamerus
Principal Investigator

Sparrow Hospital

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Lapeer

McLaren Cancer Institute-Lapeer Region

Justin F. Klamerus
Ph: 313-576-9363

Justin F. Klamerus
Principal Investigator

Livonia

Saint Mary Mercy Hospital

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Monroe

Monroe Cancer Center

Jeffrey Henry Muler
Ph: 419-824-1842

Jeffrey Henry Muler
Principal Investigator

Mount Pleasant

McLaren Cancer Institute-Central Michigan

Justin F. Klamerus
Ph: 313-576-9363

Justin F. Klamerus
Principal Investigator

Novi

Assarian Cancer Center

Rajendra Kumar Manam
Ph: 248-849-5337
Email: jaswinder.grewal@stjohn.org

Rajendra Kumar Manam
Principal Investigator

Henry Ford Medical Center-Columbus

Robert Anthony Chapman
Ph: 313-916-1784

Robert Anthony Chapman
Principal Investigator

Petoskey

McLaren Cancer Institute-Northern Michigan

Justin F. Klamerus
Ph: 313-576-9363

Justin F. Klamerus
Principal Investigator

Pontiac

Saint Joseph Mercy Oakland

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Roseville

Michigan Cancer Specialists

Ishmael A. Jaiyesimi
Ph: 248-551-7695

Ishmael A. Jaiyesimi
Principal Investigator

Royal Oak

Cancer Care Associates PC

Ishmael A. Jaiyesimi
Ph: 248-551-7695

Ishmael A. Jaiyesimi
Principal Investigator

Comprehensive Medical Center PLLC

Ishmael A. Jaiyesimi
Ph: 248-551-7695

Ishmael A. Jaiyesimi
Principal Investigator

Hematology Oncology Consultants PC

Ishmael A. Jaiyesimi
Ph: 248-551-7695

Ishmael A. Jaiyesimi
Principal Investigator

Oakland Colon and Rectal Association

Ishmael A. Jaiyesimi
Ph: 248-551-7695

Ishmael A. Jaiyesimi
Principal Investigator

Oakland Medical Group

Ishmael A. Jaiyesimi
Ph: 248-551-7695

Ishmael A. Jaiyesimi
Principal Investigator

William Beaumont Hospital-Royal Oak

Ishmael A. Jaiyesimi
Ph: 248-551-7695

Ishmael A. Jaiyesimi
Principal Investigator

Saginaw

Saint Mary's of Michigan

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Southfield

Providence Hospital-Southfield Cancer Center

Rajendra Kumar Manam
Ph: 248-849-5337
Email: jaswinder.grewal@stjohn.org

Rajendra Kumar Manam
Principal Investigator

Sterling Heights

Mitchell Folbe MD PC

Ishmael A. Jaiyesimi
Ph: 248-551-7695

Ishmael A. Jaiyesimi
Principal Investigator

Premier Hematology Oncology Care

Ishmael A. Jaiyesimi
Ph: 248-551-7695

Ishmael A. Jaiyesimi
Principal Investigator

Trenton

Downriver Center for Oncology

Robert Anthony Chapman
Ph: 313-916-1784

Robert Anthony Chapman
Principal Investigator

Troy

Claudia BR Herke MD PC

Ishmael A. Jaiyesimi
Ph: 248-551-7695

Ishmael A. Jaiyesimi
Principal Investigator

Hematology Oncology Consultants PC-Troy

Ishmael A. Jaiyesimi
Ph: 248-551-7695

Ishmael A. Jaiyesimi
Principal Investigator

Michigan Institute of Urology-Town Center

Ishmael A. Jaiyesimi
Ph: 248-551-7695

Ishmael A. Jaiyesimi
Principal Investigator

William Beaumont Hospital - Troy

Ishmael A. Jaiyesimi
Ph: 248-551-7695

Ishmael A. Jaiyesimi
Principal Investigator

Warren

Saint John Macomb-Oakland Hospital

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

West Bloomfield

Henry Ford Medical Center - West Bloomfield

Robert Anthony Chapman
Ph: 313-916-1784

Robert Anthony Chapman
Principal Investigator

Minnesota
Bemidji

Sanford Clinic North-Bemidgi

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Brainerd

Essentia Health Saint Joseph's Medical Center

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Burnsville

Fairview Ridges Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Coon Rapids

Mercy Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Duluth

Essentia Health Cancer Center

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Essentia Health Saint Mary's Medical Center

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Miller-Dwan Hospital

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Edina

Fairview-Southdale Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Fergus Falls

Lake Region Healthcare Corporation-Cancer Care

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Fridley

Unity Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Maple Grove

Fairview Maple Grove Medical Center

Daniel M. Anderson
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Daniel M. Anderson
Principal Investigator

Maplewood

Minnesota Oncology Hematology PA-Maplewood

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Saint John's Hospital - Healtheast

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Minneapolis

Abbott-Northwestern Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Health Partners Inc

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Hennepin County Medical Center

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

New Ulm

New Ulm Medical Center

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Robbinsdale

North Memorial Medical Health Center

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Rochester

Mayo Clinic

Shaji K. Kumar
Ph: 855-776-0015

Shaji K. Kumar
Principal Investigator

Saint Louis Park

Park Nicollet Clinic - Saint Louis Park

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Saint Paul

Regions Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

United Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Shakopee

Saint Francis Regional Medical Center

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Stillwater

Lakeview Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Waconia

Ridgeview Medical Center

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Willmar

Rice Memorial Hospital

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Woodbury

Minnesota Oncology Hematology PA-Woodbury

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Wyoming

Fairview Lakes Medical Center

Daniel M. Anderson
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Daniel M. Anderson
Principal Investigator

Missouri
Bolivar

Central Care Cancer Center-Carrie J Babb Cancer Center

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Bonne Terre

Parkland Health Center-Bonne Terre

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Branson

CoxHealth Cancer Center

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Cape Girardeau

Saint Francis Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Southeast Cancer Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Columbia

University of Missouri - Ellis Fischel

Clint Daniel Kingsley
Ph: 573-882-7440

Clint Daniel Kingsley
Principal Investigator

Jefferson City

Capital Region Medical Center-Goldschmidt Cancer Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Joplin

Freeman Health System

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Mercy Hospital-Joplin

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Kansas City

Kansas City Veterans Affairs Medical Center

Suman Kambhampati
Ph: 800-525-1483

Suman Kambhampati
Principal Investigator

Rolla

Phelps County Regional Medical Center

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Saint John's Clinic-Rolla-Cancer and Hematology

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Saint Louis

Mercy Hospital Saint Louis

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Missouri Baptist Medical Center

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Saint Louis Cancer and Breast Institute-South City

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Sainte Genevieve

Sainte Genevieve County Memorial Hospital

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Springfield

CoxHealth South Hospital

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Mercy Hospital Springfield

Jay W. Carlson
Ph: 800-821-7532

Jay W. Carlson
Principal Investigator

Sullivan

Missouri Baptist Sullivan Hospital

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Sunset Hills

Missouri Baptist Outpatient Center-Sunset Hills

James Lloyd Wade
Ph: 217-876-4740
Email: kcheek@dmhhs.org

James Lloyd Wade
Principal Investigator

Montana
Anaconda

Community Hospital of Anaconda

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Billings

Billings Clinic Cancer Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Saint Vincent Healthcare

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Bozeman

Bozeman Deaconess Hospital

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Great Falls

Benefis Healthcare- Sletten Cancer Institute

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Great Falls Clinic

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Helena

Saint Peter's Community Hospital

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Kalispell

Kalispell Regional Medical Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Missoula

Community Medical Hospital

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Nebraska
Grand Island

CHI Health Saint Francis

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Kearney

CHI Health Good Samaritan

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Heartland Hematology and Oncology

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Lincoln

Nebraska Cancer Research Center

Gamini S. Soori
Ph: 402-393-3110

Gamini S. Soori
Principal Investigator

Nebraska Hematology and Oncology

Gamini S. Soori
Ph: 402-393-3110

Gamini S. Soori
Principal Investigator

Saint Elizabeth Regional Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Southeast Nebraska Cancer Center

Gamini S. Soori
Ph: 402-393-3110

Gamini S. Soori
Principal Investigator

Norfolk

Faith Regional Medical Offices West

Gamini S. Soori
Ph: 402-393-3110

Gamini S. Soori
Principal Investigator

North Platte

Great Plains Regional Medical Center

Gamini S. Soori
Ph: 402-393-3110

Gamini S. Soori
Principal Investigator

Omaha

Alegent Health Bergan Mercy Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Alegent Health Immanuel Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Alegent Health Lakeside Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Creighton University Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Hemotology and Oncology Consultants PC

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Missouri Valley Cancer Consortium

Gamini S. Soori
Ph: 402-991-8070ext202
Email: mwilwerding@mvcc.cc

Gamini S. Soori
Principal Investigator

Oncology Hematology West

Gamini S. Soori
Ph: 402-393-3110

Gamini S. Soori
Principal Investigator

Oncology Hematology West PC

Gamini S. Soori
Ph: 402-393-3110

Gamini S. Soori
Principal Investigator

University of Nebraska Medical Center

Matthew Alexander Lunning
Ph: 402-559-6941
Email: unmcrsa@unmc.edu

Matthew Alexander Lunning
Principal Investigator

Papillion

Midlands Community Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Scottsbluff

Regional West Medical Center

Gamini S. Soori
Ph: 402-393-3110

Gamini S. Soori
Principal Investigator

Nevada
Carson City

Carson Tahoe Regional Medical Center

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Henderson

21st Century Oncology - Henderson

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Cancer and Blood Specialists-Henderson

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada - Henderson

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada-Southeast Henderson

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Las Vegas Cancer Center-Henderson

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Las Vegas

21st Century Oncology

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

21st Century Oncology - Fort Apache

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

21st Century Oncology - Vegas Tenaya

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Ann M Wierman MD LTD

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Cancer and Blood Specialists-Fort Apache

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Cancer and Blood Specialists-Shadow

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Cancer and Blood Specialists-Tenaya

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Cancer Therapy and Integrative Medicine

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Children's Specialty Center of Nevada II

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada - Central Valley

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada - Northwest

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Comprehensive Cancer Centers of Nevada-Summerlin

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-San Martin

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

HealthCare Partners Medical Group Oncology/Hematology-Tenaya

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Las Vegas Cancer Center-Medical Center

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Nevada Cancer Research Foundation CCOP

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Radiation Oncology Centers of Nevada Central

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Radiation Oncology Centers of Nevada Southeast

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Summerlin Hospital Medical Center

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

University Cancer Center

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Reno

Renown Regional Medical Center

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

Saint Mary's Regional Medical Center

John Allan Ellerton
Ph: 702-384-0013

John Allan Ellerton
Principal Investigator

New Jersey
East Orange

Veterans Adminstration New Jersey Health Care System

Victor Tsu-Shih Chang
Ph: 800-475-2336
Email: patricia.goyer@med.va.gov

Victor Tsu-Shih Chang
Principal Investigator

New Brunswick

Rutgers Cancer Institute of New Jersey

Mecide Meric Gharibo
Ph: 732-235-8675

Mecide Meric Gharibo
Principal Investigator

Newark

Newark Beth Israel Medical Center

Lori Schleicher
Ph: 973-926-7230

Lori Schleicher
Principal Investigator

Vineland

Inspira Medical Center Vineland

Ramakrishna R. Sudhindra
Ph: 856-641-7933

Ramakrishna R. Sudhindra
Principal Investigator

Woodbury

Inspira Medical Center Woodbury

Tami Lee Bach
Ph: 856-641-7933

Tami Lee Bach
Principal Investigator

New Mexico
Albuquerque

University of New Mexico Cancer Center

Dulcinea Dolores Quintana
Ph: 505-925-0366
Email: LByatt@nmcca.org

Dulcinea Dolores Quintana
Principal Investigator

Las Cruces

Memorial Medical Center - Las Cruces

Montaser Shaheen
Ph: 505-925-0366
Email: LByatt@nmcca.org

Montaser Shaheen
Principal Investigator

New York
Cooperstown

Mary Imogene Bassett Hospital

Eric Bravin
Ph: 607-547-3073
Email: diana.crean@bassett.org

Eric Bravin
Principal Investigator

Plattsburgh

Champlain Valley Physicians Hospital Medical Center

Jan Erik Duus
Ph: 518-561-2000

Jan Erik Duus
Principal Investigator

Syracuse

State University of New York Upstate Medical University

Teresa Caroline Gentile
Ph: 315-464-5476

Teresa Caroline Gentile
Principal Investigator

North Carolina
Asheboro

Randolph Hospital

James Mitchell Granfortuna
Ph: 336-832-0821

James Mitchell Granfortuna
Principal Investigator

Asheville

Asheville Hematology-Oncology Associates

Raymond Thertulien
Ph: 855-774-5433

Raymond Thertulien
Principal Investigator

Mission Hospital-Memorial Campus

Christopher H. Chay
Ph: 800-506-2550

Christopher H. Chay
Principal Investigator

Burlington

Cone Health Cancer Center at Alamance Regional

James Mitchell Granfortuna
Ph: 336-832-0821

James Mitchell Granfortuna
Principal Investigator

Clinton

Southeastern Medical Oncology Center-Clinton

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Goldsboro

Southeastern Medical Oncology Center-Goldsboro

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Wayne Memorial Hospital

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Greensboro

Cone Health Cancer Center

James Mitchell Granfortuna
Ph: 336-832-0821

James Mitchell Granfortuna
Principal Investigator

Hendersonville

Hendersonville Hematology and Oncology at Pardee

James Earl Radford
Ph: 828-696-4716

James Earl Radford
Principal Investigator

Margaret R Pardee Memorial Hospital

James Earl Radford
Ph: 828-696-4716

James Earl Radford
Principal Investigator

Park Ridge Hospital Breast Health Center

Raymond Thertulien
Ph: 855-774-5433

Raymond Thertulien
Principal Investigator

Jacksonville

Onslow Memorial Hospital

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Southeastern Medical Oncology Center-Jacksonville

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Kinston

Kinston Medical Specialists PA

Peter Robins Watson
Ph: 252-559-2200

Peter Robins Watson
Principal Investigator

Mebane

Cone Heath Cancer Center at Mebane

James Mitchell Granfortuna
Ph: 336-832-0821

James Mitchell Granfortuna
Principal Investigator

Pinehurst

FirstHealth of the Carolinas-Moore Regional Hosiptal

Charles S. Kuzma
Ph: 910-715-2200

Charles S. Kuzma
Principal Investigator

Reidsville

Annie Penn Memorial Hospital

James Mitchell Granfortuna
Ph: 336-832-0821

James Mitchell Granfortuna
Principal Investigator

Statesville

Iredell Memorial Hospital

Ruby Ann Grimm
Ph: 704-873-5661

Ruby Ann Grimm
Principal Investigator

Wilson

Southeastern Medical Oncology Center-Wilson

James N. Atkins
Ph: 919-580-0000

James N. Atkins
Principal Investigator

Winston-Salem

Wake Forest University Health Sciences

Rakhee Vaidya
Ph: 416-946-4501
Email: clinical.trials@uhn.on.ca

Rakhee Vaidya
Principal Investigator

North Dakota
Bismarck

Sanford Bismarck Medical Center

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Fargo

Essentia Health Cancer Center-South University Clinic

Bret E.B. Friday
Ph: 888-203-7267

Bret E.B. Friday
Principal Investigator

Roger Maris Cancer Center

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Sanford Clinic North-Fargo

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Sanford Medical Center-Fargo

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Ohio
Belpre

Strecker Cancer Center-Belpre

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Canton

Aultman Health Foundation

James A. Schmotzer
Ph: 330-363-6891

James A. Schmotzer
Principal Investigator

Mercy Medical Center

Mitchell Haut
Ph: 888-293-4673

Mitchell Haut
Principal Investigator

Centerville

Dayton Physicians LLC-Miami Valley South

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Miami Valley Hospital South

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Chillicothe

Adena Regional Medical Center

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Cincinnati

Bethesda North Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Good Samaritan Hospital - Cincinnati

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Oncology Hematology Care Inc - Anderson

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Oncology Hematology Care Inc-Blue Ash

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Oncology Hematology Care Inc-Eden Park

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Oncology Hematology Care Inc-Kenwood

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Oncology Hematology Care Inc-Mercy West

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

TriHealth Cancer Institute-Anderson

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

TriHealth Cancer Institute-Westside

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Cleveland

MetroHealth Medical Center

Bruce J. Averbook
Ph: 216-778-8526
Email: kbauchens@metrohealth.org

Bruce J. Averbook
Principal Investigator

Columbus

Columbus Oncology and Hematology Associates Inc

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Doctors Hospital

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Grant Medical Center

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Mount Carmel Health Center West

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Riverside Methodist Hospital

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

The Mark H Zangmeister Center

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Dayton

Dayton Physicians LLC-Samaritan North

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Good Samaritan Hospital - Dayton

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Miami Valley Hospital

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Samaritan North Health Center

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Delaware

Delaware Health Center-Grady Cancer Center

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Delaware Radiation Oncology

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Grady Memorial Hospital

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Fairfield

Oncology Hematology Care Inc-Healthplex

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Findlay

Armes Family Cancer Center

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Blanchard Valley Hospital

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Orion Cancer Care

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Franklin

Atrium Medical Center-Middletown Regional Hospital

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Dayton Physicians LLC-Atrium

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Greenville

Dayton Physicians LLC-Wayne

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Wayne Hospital

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Kettering

Greater Dayton Cancer Center

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Kettering Medical Center

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Lancaster

Fairfield Medical Center

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Lima

Saint Rita's Medical Center

Chris Allen Rhoades
Ph: 419-226-9617

Chris Allen Rhoades
Principal Investigator

Mansfield

OhioHealth Mansfield Hospital

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Marietta

Marietta Memorial Hospital

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Middletown

Dayton Physicians LLC-Signal Point

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Mount Vernon

Knox Community Hospital

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Newark

Licking Memorial Hospital

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Newark Radiation Oncology

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Portsmouth

Southern Ohio Medical Center

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Sidney

Dayton Physicians LLC-Wilson

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Springfield

Springfield Regional Cancer Center

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Springfield Regional Medical Center

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Sylvania

Flower Hospital

Jeffrey Henry Muler
Ph: 419-824-1842

Jeffrey Henry Muler
Principal Investigator

Troy

Dayton Physicians LLC-Upper Valley

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Upper Valley Medical Center

Howard M. Gross
Ph: 937-775-1350
Email: som_dcop@wright.edu

Howard M. Gross
Principal Investigator

Westerville

Saint Ann's Hospital

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Wright-Patterson Afb

Wright-Patterson Medical Center

Susannah Catherine Cooper
Ph: 937-775-1350
Email: som_dcop@wright.edu

Susannah Catherine Cooper
Principal Investigator

Zanesville

Genesis Healthcare System Cancer Care Center

Timothy David Moore
Ph: 614-488-2745
Email: sheree@columbusccop.org

Timothy David Moore
Principal Investigator

Oklahoma
Oklahoma City

Integris Southwest Medical Center

Alexandra P. Ikeguchi
Ph: 405-271-8777
Email: ou-clinical-trials@ouhsc.edu

Alexandra P. Ikeguchi
Principal Investigator

University of Oklahoma Health Sciences Center

Alexandra P. Ikeguchi
Ph: 405-271-8777
Email: ou-clinical-trials@ouhsc.edu

Alexandra P. Ikeguchi
Principal Investigator

Tulsa

Oklahoma Cancer Specialists and Research Institute-Tulsa

Alexandra P. Ikeguchi
Ph: 405-271-8777
Email: ou-clinical-trials@ouhsc.edu

Alexandra P. Ikeguchi
Principal Investigator

Oregon
Gresham

Legacy Mount Hood Medical Center

Jacqueline Vuky
Ph: 503-299-6500

Jacqueline Vuky
Principal Investigator

Portland

Legacy Good Samaritan Hospital and Medical Center

Jacqueline Vuky
Ph: 503-299-6500

Jacqueline Vuky
Principal Investigator

Oregon Health and Science University

Eva Medvedova
Ph: 503-494-1080
Email: trials@ohsu.edu

Eva Medvedova
Principal Investigator

Tualatin

Legacy Meridian Park Hospital

Jacqueline Vuky
Ph: 503-299-6500

Jacqueline Vuky
Principal Investigator

Pennsylvania
Allentown

Lehigh Valley Hospital-Cedar Crest

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Bethlehem

Lehigh Valley Hospital - Muhlenberg

Christopher M. Reynolds
Ph: 734-712-4673

Christopher M. Reynolds
Principal Investigator

Chadds Ford

Christiana Care Health System-Concord Health Center

Gregory Andrew Masters
Ph: 302-733-6227

Gregory Andrew Masters
Principal Investigator

Danville

Geisinger Medical Center

Joseph Joe Lukose Vadakara
Ph: 570-271-5251

Joseph Joe Lukose Vadakara
Principal Investigator

Ephrata

Ephrata Cancer Center

Amir Tabatabai
Ph: 877-441-7957

Amir Tabatabai
Principal Investigator

Ephrata Community Hospital

Amir Tabatabai
Ph: 877-441-7957

Amir Tabatabai
Principal Investigator

Gettysburg

Adams Cancer Center

Amir Tabatabai
Ph: 877-441-7957

Amir Tabatabai
Principal Investigator

Hanover

Cherry Tree Cancer Center

Amir Tabatabai
Ph: 877-441-7957

Amir Tabatabai
Principal Investigator

Hazleton

Geisinger Medical Center-Cancer Center Hazleton

Joseph Joe Lukose Vadakara
Ph: 570-271-5251

Joseph Joe Lukose Vadakara
Principal Investigator

Hershey

Penn State Milton S Hershey Medical Center

Witold B. Rybka
Ph: 717-531-3779
Email: CTO@hmc.psu.edu

Witold B. Rybka
Principal Investigator

Lewisburg

Geisinger Medical Oncology-Lewisburg

Joseph Joe Lukose Vadakara
Ph: 570-271-5251

Joseph Joe Lukose Vadakara
Principal Investigator

Lewistown

Lewistown Hospital

Joseph Joe Lukose Vadakara
Ph: 570-271-5251

Joseph Joe Lukose Vadakara
Principal Investigator

Philadelphia

University of Pennsylvania/Abramson Cancer Center

Adam David Cohen
Ph: 800-474-9892

Adam David Cohen
Principal Investigator

Phoenixville

Phoenixville Hospital

Carl W. Sharer
Ph: 610-983-1908

Carl W. Sharer
Principal Investigator

Pottsville

Geisinger Medical Oncology-Pottsville

Joseph Joe Lukose Vadakara
Ph: 570-271-5251

Joseph Joe Lukose Vadakara
Principal Investigator

Reading

Penn State Health Saint Joseph Medical Center

Marc A. Rovito
Ph: 610-378-2336
Email: danielward2@catholichealth.net

Marc A. Rovito
Principal Investigator

Selinsgrove

Geisinger Medical Oncology-Selinsgrove

Joseph Joe Lukose Vadakara
Ph: 570-271-5251

Joseph Joe Lukose Vadakara
Principal Investigator

State College

Geisinger Medical Group

Joseph Joe Lukose Vadakara
Ph: 570-271-5251

Joseph Joe Lukose Vadakara
Principal Investigator

West Chester

Chester County Hospital

William Emil Luginbuhl
Ph: 610-431-5297

William Emil Luginbuhl
Principal Investigator

West Reading

Reading Hospital

Terrence Paul Cescon
Ph: 610-988-9323

Terrence Paul Cescon
Principal Investigator

Wilkes-Barre

Geisinger Wyoming Valley/Henry Cancer Center

Joseph Joe Lukose Vadakara
Ph: 570-271-5251

Joseph Joe Lukose Vadakara
Principal Investigator

York

WellSpan Health-York Cancer Center

Amir Tabatabai
Ph: 877-441-7957

Amir Tabatabai
Principal Investigator

WellSpan Health-York Hospital

Amir Tabatabai
Ph: 877-441-7957

Amir Tabatabai
Principal Investigator

South Carolina
Easley

Greenville Health System Cancer Institute-Easley

Jeffrey Kent Giguere
Ph: 864-241-6251

Jeffrey Kent Giguere
Principal Investigator

Greenville

Greenville Health System Cancer Institute-Butternut

Jeffrey Kent Giguere
Ph: 864-241-6251

Jeffrey Kent Giguere
Principal Investigator

Greenville Health System Cancer Institute-Eastside

Jeffrey Kent Giguere
Ph: 864-241-6251

Jeffrey Kent Giguere
Principal Investigator

Greenville Health System Cancer Institute-Faris

Jeffrey Kent Giguere
Ph: 864-241-6251

Jeffrey Kent Giguere
Principal Investigator

Greenville Memorial Hospital

Jeffrey Kent Giguere
Ph: 864-241-6251

Jeffrey Kent Giguere
Principal Investigator

Saint Francis Cancer Center

Robert D. Siegel
Ph: 864-255-1713

Robert D. Siegel
Principal Investigator

Saint Francis Hospital

Robert D. Siegel
Ph: 864-255-1713

Robert D. Siegel
Principal Investigator

Greer

Greenville Health System Cancer Institute-Greer

Jeffrey Kent Giguere
Ph: 864-241-6251

Jeffrey Kent Giguere
Principal Investigator

Seneca

Greenville Health System Cancer Institute-Seneca

Jeffrey Kent Giguere
Ph: 864-241-6251

Jeffrey Kent Giguere
Principal Investigator

Spartanburg

Greenville Health System Cancer Institute-Spartanburg

Jeffrey Kent Giguere
Ph: 864-241-6251

Jeffrey Kent Giguere
Principal Investigator

South Dakota
Aberdeen

Avera Cancer Institute-Aberdeen

Vinod Parameswaran
Ph: 888-634-7268
Email: oncregulatory@avera.org

Vinod Parameswaran
Principal Investigator

Rapid City

Rapid City Regional Hospital

Joshua Cole Lukenbill
Ph: 605-716-3982
Email: research@rcrh.org

Joshua Cole Lukenbill
Principal Investigator

Sioux Falls

Avera Cancer Institute

Vinod Parameswaran
Ph: 888-634-7268
Email: oncregulatory@avera.org

Vinod Parameswaran
Principal Investigator

Sanford Cancer Center-Oncology Clinic

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Sanford USD Medical Center - Sioux Falls

Preston D. Steen
Ph: 701-234-6161

Preston D. Steen
Principal Investigator

Tennessee
Chattanooga

Memorial Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Cookeville

Cookeville Regional Medical Center

Venumadhav R. Kotla
Ph: 931-783-2714

Venumadhav R. Kotla
Principal Investigator

Hixson

Pulmonary Medicine Center of Chattanooga-Hixson

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Nashville

Meharry Medical College

Philip Edward Lammers
Ph: 615-327-5724
Email: jmurray@mmc.edu

Philip Edward Lammers
Principal Investigator

Ooltewah

Memorial GYN Plus

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Texas
Abilene

Hendrick Medical Center

Christopher J. Trauth
Ph: 888-823-5923
Email: ctsucontact@westat.com

Christopher J. Trauth
Principal Investigator

Bryan

Saint Joseph Regional Cancer Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Houston

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center

Martha Pritchett Mims
Ph: 713-798-1354
Email: burton@bcm.edu

Martha Pritchett Mims
Principal Investigator

Ben Taub General Hospital

Martha Pritchett Mims
Ph: 713-798-1354
Email: burton@bcm.edu

Martha Pritchett Mims
Principal Investigator

Michael E DeBakey VA Medical Center

Sarvari Venkata Yellapragada
Ph: 800-553-2278

Sarvari Venkata Yellapragada
Principal Investigator

San Antonio

Cancer Therapy and Research Center at The UT Health Science Center at San Antonio

Sumit Madan
Ph: 210-450-3800

Sumit Madan
Principal Investigator

University Hospital

Sumit Madan
Ph: 210-450-3800

Sumit Madan
Principal Investigator

University of Texas Health Science Center at San Antonio

Sumit Madan
Ph: 210-450-3800

Sumit Madan
Principal Investigator

Virginia
Charlottesville

University of Virginia Cancer Center

Laahn Ho Foster
Ph: 434-243-6322
Email: JME3D@hscmail.mcc.virginia.edu

Laahn Ho Foster
Principal Investigator

Fredericksburg

Hematology Oncology Associates of Fredericksburg Inc

Beata Holkova
Ph: 804-628-1939

Beata Holkova
Principal Investigator

Richmond

Virginia Commonwealth University/Massey Cancer Center

Beata Holkova
Ph: 804-628-1939

Beata Holkova
Principal Investigator

Washington
Bremerton

Harrison HealthPartners Hematology and Oncology-Bremerton

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Harrison Medical Center

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Burien

Highline Medical Center-Main Campus

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Enumclaw

Saint Elizabeth Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Federal Way

Saint Francis Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Lakewood

Saint Clare Hospital

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Poulsbo

Harrison HealthPartners Hematology and Oncology-Poulsbo

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Tacoma

Franciscan Research Center-Northwest Medical Plaza

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Northwest Medical Specialties PLLC

Mehmet Sitki Copur
Ph: 800-998-2119

Mehmet Sitki Copur
Principal Investigator

Vancouver

Legacy Salmon Creek Hospital

Jacqueline Vuky
Ph: 503-299-6500

Jacqueline Vuky
Principal Investigator

West Virginia
Bridgeport

United Hospital Center

Abraham Sebastian Kanate
Ph: 304-293-7374
Email: cancertrialsinfo@hsc.wvu.edu

Abraham Sebastian Kanate
Principal Investigator

Charleston

West Virginia University Charleston

Steven James Jubelirer
Ph: 304-344-3457

Steven James Jubelirer
Principal Investigator

Martinsburg

WVUH-East City Hospital

Abraham Sebastian Kanate
Ph: 304-293-7374
Email: cancertrialsinfo@hsc.wvu.edu

Abraham Sebastian Kanate
Principal Investigator

Morgantown

West Virginia University Healthcare

Abraham Sebastian Kanate
Ph: 304-293-7374
Email: cancertrialsinfo@hsc.wvu.edu

Abraham Sebastian Kanate
Principal Investigator

Wisconsin
Antigo

Langlade Hospital and Cancer Center

Hamied R. Rezazadeh
Ph: 877-405-6866

Hamied R. Rezazadeh
Principal Investigator

Burlington

Aurora Cancer Care-Burlington

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Chippewa Falls

Marshfield Clinic-Chippewa Center

Adedayo A. Onitilo
Ph: 715-393-1400

Adedayo A. Onitilo
Principal Investigator

Eau Claire

Marshfield Clinic Cancer Center at Sacred Heart

Adedayo A. Onitilo
Ph: 715-393-1400

Adedayo A. Onitilo
Principal Investigator

Sacred Heart Hospital

Adedayo A. Onitilo
Ph: 715-393-1400

Adedayo A. Onitilo
Principal Investigator

Elkhorn

Aurora Cancer Care-Southern Lakes

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Fond Du Lac

Aurora Health Center-Fond du Lac

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Germantown

Aurora Health Care Germantown Health Center

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Grafton

Aurora Cancer Care-Grafton

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Green Bay

Aurora BayCare Medical Center

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Bellin Memorial Hospital

Hassan I. Tahsildar
Ph: 920-435-8326

Hassan I. Tahsildar
Principal Investigator

Green Bay Oncology at Saint Vincent Hospital

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Green Bay Oncology Limited at Saint Mary's Hospital

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

HSHS Saint Vincent Hospital Regional Cancer Center

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Saint Mary's Hospital

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Janesville

Mercy Health System

Emily Gray Robinson
Ph: 800-928-1103

Emily Gray Robinson
Principal Investigator

Johnson Creek

UW Cancer Center Johnson Creek

Natalie Scott Callander
Ph: 877-405-6866

Natalie Scott Callander
Principal Investigator

Kenosha

Aurora Cancer Care-Kenosha South

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

La Crosse

Gundersen Lutheran Medical Center

Kurt Oettel
Ph: 608-775-2385
Email: cancerctr@gundersenhealth.org

Kurt Oettel
Principal Investigator

Ladysmith

Marshfield Clinic - Ladysmith Center

Adedayo A. Onitilo
Ph: 715-393-1400

Adedayo A. Onitilo
Principal Investigator

Madison

Dean Hematology and Oncology Clinic

Amit Sanyal
Ph: 608-410-2700

Amit Sanyal
Principal Investigator

University of Wisconsin Hospital and Clinics

Natalie Scott Callander
Ph: 877-405-6866

Natalie Scott Callander
Principal Investigator

William S Middleton VA Medical Center

Natalie Scott Callander
Ph: 877-405-6866

Natalie Scott Callander
Principal Investigator

Manitowoc

Holy Family Memorial Hospital

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Marshfield

Marshfield Clinic

Adedayo A. Onitilo
Ph: 715-393-1400

Adedayo A. Onitilo
Principal Investigator

Saint Joseph's Hospital

Adedayo A. Onitilo
Ph: 715-393-1400

Adedayo A. Onitilo
Principal Investigator

Milwaukee

Aurora Cancer Care-Milwaukee

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Aurora Cancer Care-Milwaukee South

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Aurora Saint Luke's Medical Center

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Aurora Sinai Medical Center

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Minocqua

Marshfield Clinic-Minocqua Center

Adedayo A. Onitilo
Ph: 715-393-1400

Adedayo A. Onitilo
Principal Investigator

Mukwonago

D N Greenwald Center

Timothy Robert Wassenaar
Ph: 262-928-5539
Email: Chanda.miller@phci.org

Timothy Robert Wassenaar
Principal Investigator

New Richmond

Cancer Center of Western Wisconsin

Joseph W. Leach
Ph: 952-993-1517
Email: mmcorc@parknicollet.com

Joseph W. Leach
Principal Investigator

Oconomowoc

Oconomowoc Memorial Hospital-ProHealth Care Inc

Timothy Robert Wassenaar
Ph: 262-928-5539
Email: Chanda.miller@phci.org

Timothy Robert Wassenaar
Principal Investigator

Oconto Falls

Green Bay Oncology - Oconto Falls

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Oshkosh

Vince Lombardi Cancer Clinic - Oshkosh

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Racine

Aurora Cancer Care-Racine

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Rice Lake

Marshfield Clinic-Rice Lake Center

Adedayo A. Onitilo
Ph: 715-393-1400

Adedayo A. Onitilo
Principal Investigator

Sheboygan

Saint Nicholas Hospital

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Vince Lombardi Cancer Clinic-Sheboygan

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Stevens Point

Marshfield Clinic Cancer Care at Saint Michael's Hospital

Adedayo A. Onitilo
Ph: 715-393-1400

Adedayo A. Onitilo
Principal Investigator

Saint Michael's Hospital

Adedayo A. Onitilo
Ph: 715-393-1400

Adedayo A. Onitilo
Principal Investigator

Sturgeon Bay

Green Bay Oncology - Sturgeon Bay

Brian Leslie Burnette
Ph: 800-432-6049

Brian Leslie Burnette
Principal Investigator

Summit

Aurora Medical Center in Summit

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Two Rivers

Vince Lombardi Cancer Clinic

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Waukesha

UW Cancer Center at ProHealth Care

Timothy Robert Wassenaar
Ph: 262-928-5539
Email: Chanda.miller@phci.org

Timothy Robert Wassenaar
Principal Investigator

Waukesha Memorial Hospital

Timothy Robert Wassenaar
Ph: 262-928-5539
Email: Chanda.miller@phci.org

Timothy Robert Wassenaar
Principal Investigator

Wausau

Aspirus Regional Cancer Center

Hamied R. Rezazadeh
Ph: 877-405-6866

Hamied R. Rezazadeh
Principal Investigator

Marshfield Clinic-Wausau Center

Adedayo A. Onitilo
Ph: 715-393-1400

Adedayo A. Onitilo
Principal Investigator

Wauwatosa

Aurora Cancer Care-Milwaukee West

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

West Allis

Aurora West Allis Medical Center

Dhimant R. Patel
Ph: 800-252-2990

Dhimant R. Patel
Principal Investigator

Weston

Diagnostic and Treatment Center

Adedayo A. Onitilo
Ph: 715-393-1400

Adedayo A. Onitilo
Principal Investigator

Marshfield Clinic - Weston Center

Adedayo A. Onitilo
Ph: 715-393-1400

Adedayo A. Onitilo
Principal Investigator

Saint Clare's Hospital

Adedayo A. Onitilo
Ph: 715-393-1400

Adedayo A. Onitilo
Principal Investigator

Wisconsin Rapids

Aspirus UW Cancer Center

Hamied R. Rezazadeh
Ph: 877-405-6866

Hamied R. Rezazadeh
Principal Investigator

Marshfield Clinic - Wisconsin Rapids Center

Adedayo A. Onitilo
Ph: 715-393-1400

Adedayo A. Onitilo
Principal Investigator

Wyoming
Cheyenne

Cheyenne Regional Medical Center-West

Keren Sturtz
Ph: 303-777-2663
Email: kgeisen@co-cancerresearch.org

Keren Sturtz
Principal Investigator

Cody

Billings Clinic-Cody

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Sheridan

Welch Cancer Center

Benjamin T. Marchello
Ph: 800-648-6274

Benjamin T. Marchello
Principal Investigator

Link to the current ClinicalTrials.gov record.
NLM Identifier NCT01863550

Note: Information about participating sites on pharmaceutical industry trials may be incomplete. Please visit the ClinicalTrials.gov record via the link above for more information about participating sites.